Raymond James & Associates’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
Other funds holding IOSP
WA
RA
Raymond James & Associates's IOSP Position: Q3 2024 in Review
Raymond James & Associates increased its Innospec (IOSP) stake by 10% in Q3 2024, buying an estimated $887K and bringing the position to 83,843 shares worth $9.48M. The position accounts for 0.01% of the portfolio, ranked #1263.
Raymond James & Associates first reported a position in IOSP in Q1 2016 and has held it in 26 quarters since. The position peaked at $10.9M in Q1 2024. 259 funds tracked by Wall St. Rank hold IOSP as of Q3 2024.
- Raymond James & Associates held 83,843 shares of Innospec worth $9.48M as of Q3 2024.
- Raymond James & Associates bought 7,616 Innospec shares in Q3 2024, an estimated $887K.
- Innospec made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1263 holding.
- Raymond James & Associates first reported a position in Innospec in Q1 2016 and has held it in 26 quarters since.
- Raymond James & Associates's Innospec position peaked at $10.9M in Q1 2024.
- 259 funds tracked by Wall St. Rank held Innospec as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.